{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2007-D-0369\" and posted_year = 2025 sorted by posted_date descending", "rows": [["FDA-2007-D-0369-2421", "FDA", "FDA-2007-D-0369", "PSG_208564 Draft Guidance on Estradiol", "Other", "Guidance", "2025-12-16T05:00:00Z", 2025, 12, "2025-12-16T05:00:00Z", null, "2025-12-16T20:30:49Z", null, 1, 0, "09000064b90dccd3"], ["FDA-2007-D-0369-2420", "FDA", "FDA-2007-D-0369", "PSG_020908 Draft Guidance on Estradiol", "Other", "Guidance", "2025-12-16T05:00:00Z", 2025, 12, "2025-12-16T05:00:00Z", null, "2025-12-16T20:27:46Z", null, 1, 0, "09000064b90dccd1"], ["FDA-2007-D-0369-2419", "FDA", "FDA-2007-D-0369", "Product-Specific Guidance on Estradiol; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2025-12-08T05:00:00Z", 2025, 12, "2025-12-08T05:00:00Z", null, "2025-12-09T00:20:26Z", "2025-22249", 0, 0, "09000064b90b585d"], ["FDA-2007-D-0369-2338", "FDA", "FDA-2007-D-0369", "PSG_216540 - Draft Guidance on Acoramidis Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:42:47Z", null, 1, 0, "09000064b90ae511"], ["FDA-2007-D-0369-2409", "FDA", "FDA-2007-D-0369", "PSG_215272 - Draft Guidance on Tapinarof", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:18Z", null, 1, 0, "09000064b90aee6c"], ["FDA-2007-D-0369-2392", "FDA", "FDA-2007-D-0369", "PSG_215014 - Draft Guidance on Pegcetacoplan", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:17Z", null, 1, 0, "09000064b90aee4a"], ["FDA-2007-D-0369-2407", "FDA", "FDA-2007-D-0369", "PSG_219209 - Draft Guidance on Suzetrigine", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:08Z", null, 1, 0, "09000064b90aee68"], ["FDA-2007-D-0369-2402", "FDA", "FDA-2007-D-0369", "PSG_218944 - Draft Guidance on Revumenib Citrate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:43Z", null, 1, 0, "09000064b90aee5e"], ["FDA-2007-D-0369-2388", "FDA", "FDA-2007-D-0369", "PSG_022000 - Draft Guidance on Mesalamine", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:09:56Z", null, 1, 0, "09000064b90aee42"], ["FDA-2007-D-0369-2360", "FDA", "FDA-2007-D-0369", "PSG_020062 - Draft Guidance on Diltiazem Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:48:31Z", null, 1, 0, "09000064b90aee05"], ["FDA-2007-D-0369-2382", "FDA", "FDA-2007-D-0369", "PSG_211913 - Draft Guidance on Isotretinoin", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:51Z", null, 1, 0, "09000064b90aee34"], ["FDA-2007-D-0369-2351", "FDA", "FDA-2007-D-0369", "PSG_022012 - Draft Guidance on Carvedilol Phosphate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:46:04Z", null, 1, 0, "09000064b90ae582"], ["FDA-2007-D-0369-2366", "FDA", "FDA-2007-D-0369", "PSG_214697 - Draft Guidance on Epinephrine", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:50:08Z", null, 1, 0, "09000064b90aee11"], ["FDA-2007-D-0369-2374", "FDA", "FDA-2007-D-0369", "PSG_218230 - Draft Guidance on Gepotidacin Mesylate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:55:39Z", null, 1, 0, "09000064b90aee21"], ["FDA-2007-D-0369-2369", "FDA", "FDA-2007-D-0369", "PSG_210132 - Draft Guidance on Estradiol; Progesterone", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:51:18Z", null, 1, 0, "09000064b90aee17"], ["FDA-2007-D-0369-2377", "FDA", "FDA-2007-D-0369", "PSG_219141 - Draft Guidance on Hydrochlorothiazide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:10Z", null, 1, 0, "09000064b90aee27"], ["FDA-2007-D-0369-2379", "FDA", "FDA-2007-D-0369", "PSG_214581 - Draft Guidance on Hydroxychloroquine Sulfate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:28Z", null, 1, 0, "09000064b90aee2b"], ["FDA-2007-D-0369-2344", "FDA", "FDA-2007-D-0369", "PSG_208772 - Draft Guidance on Brigatinib", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:44:15Z", null, 1, 0, "09000064b90ae576"], ["FDA-2007-D-0369-2393", "FDA", "FDA-2007-D-0369", "PSG_214511 - Draft Guidance on Pegulicianine Acetate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:23Z", null, 1, 0, "09000064b90aee4c"], ["FDA-2007-D-0369-2411", "FDA", "FDA-2007-D-0369", "PSG_021318 - Draft Guidance on Teriparatide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:28Z", null, 1, 0, "09000064b90aee70"], ["FDA-2007-D-0369-2412", "FDA", "FDA-2007-D-0369", "PSG_208088 - Draft Guidance on Testosterone Undecanoate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:33Z", null, 1, 0, "09000064b90aee72"], ["FDA-2007-D-0369-2401", "FDA", "FDA-2007-D-0369", "PSG_009829 - Draft Guidance on Pyridostigmine Bromide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:35Z", null, 1, 0, "09000064b90aee5c"], ["FDA-2007-D-0369-2404", "FDA", "FDA-2007-D-0369", "PSG_218160 - Draft Guidance on Selpercatinib", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:53Z", null, 1, 0, "09000064b90aee62"], ["FDA-2007-D-0369-2383", "FDA", "FDA-2007-D-0369", "PSG_208462 - Draft Guidance on Ixazomib Citrate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:59Z", null, 1, 0, "09000064b90aee38"], ["FDA-2007-D-0369-2367", "FDA", "FDA-2007-D-0369", "PSG_021323-ODT - Draft Guidance on Escitalopram Oxalate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:50:24Z", null, 1, 0, "09000064b90aee13"], ["FDA-2007-D-0369-2385", "FDA", "FDA-2007-D-0369", "PSG_219132 - Draft Guidance on Levacetylleucine", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:57:14Z", null, 1, 0, "09000064b90aee3c"], ["FDA-2007-D-0369-2368", "FDA", "FDA-2007-D-0369", "PSG_214846 - Draft Guidance on Estradiol; Norethindrone Acetate; Relugolix", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:50:41Z", null, 1, 0, "09000064b90aee15"], ["FDA-2007-D-0369-2353", "FDA", "FDA-2007-D-0369", "PSG_212839 - Draft Guidance on Cenobamate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:46:32Z", null, 1, 0, "09000064b90ae586"], ["FDA-2007-D-0369-2343", "FDA", "FDA-2007-D-0369", "PSG_215064 - Draft Guidance on Birch Triterpenes", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2026-02-07T13:12:43Z", null, 1, 0, "09000064b90ae574"], ["FDA-2007-D-0369-2375", "FDA", "FDA-2007-D-0369", "PSG_212097 - Draft Guidance on Glucagon", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:55:54Z", null, 1, 0, "09000064b90aee23"], ["FDA-2007-D-0369-2362", "FDA", "FDA-2007-D-0369", "PSG_218860 - Draft Guidance on Elafibranor", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:49:00Z", null, 1, 0, "09000064b90aee09"], ["FDA-2007-D-0369-2365", "FDA", "FDA-2007-D-0369", "PSG_019430 - Draft Guidance on Epinephrine", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:49:53Z", null, 1, 0, "09000064b90aee0f"], ["FDA-2007-D-0369-2381", "FDA", "FDA-2007-D-0369", "PSG_216017 - Draft Guidance on Iomeprol", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:43Z", null, 1, 0, "09000064b90aee2f"], ["FDA-2007-D-0369-2370", "FDA", "FDA-2007-D-0369", "PSG_018922-Tab - Draft Guidance on Etodolac", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:54:41Z", null, 1, 0, "09000064b90aee19"], ["FDA-2007-D-0369-2364", "FDA", "FDA-2007-D-0369", "PSG_218171 - Draft Guidance on Ensartinib Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:49:32Z", null, 1, 0, "09000064b90aee0d"], ["FDA-2007-D-0369-2356", "FDA", "FDA-2007-D-0369", "PSG_202806 - Draft Guidance on Dabrafenib Mesylate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:47:14Z", null, 1, 0, "09000064b90ae58c"], ["FDA-2007-D-0369-2339", "FDA", "FDA-2007-D-0369", "PSG_214056 - Draft Guidance on Apomorphine Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:43:17Z", null, 1, 0, "09000064b90ae56c"], ["FDA-2007-D-0369-2398", "FDA", "FDA-2007-D-0369", "PSG_009170-ODT - Draft Guidance on Primidone", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:00Z", null, 1, 0, "09000064b90aee56"], ["FDA-2007-D-0369-2399", "FDA", "FDA-2007-D-0369", "PSG_015193 - Draft Guidance on Pyridostigmine Bromide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:06Z", null, 1, 0, "09000064b90aee58"], ["FDA-2007-D-0369-2414", "FDA", "FDA-2007-D-0369", "PSG_214759 - Draft Guidance on Treosulfan", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:43Z", null, 1, 0, "09000064b90aee76"], ["FDA-2007-D-0369-2397", "FDA", "FDA-2007-D-0369", "PSG_017469 - Draft Guidance on Prednisolone Acetate", "Other", "Letter(s)", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:44Z", null, 1, 0, "09000064b90aee54"], ["FDA-2007-D-0369-2390", "FDA", "FDA-2007-D-0369", "PSG_021636 - Draft Guidance on Omeprazole; Sodium Bicarbonate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:07Z", null, 1, 0, "09000064b90aee46"], ["FDA-2007-D-0369-2417", "FDA", "FDA-2007-D-0369", "PSG_022103 - Draft Guidance on Trospium Chloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:13:00Z", null, 1, 0, "09000064b90aee7c"], ["FDA-2007-D-0369-2405", "FDA", "FDA-2007-D-0369", "PSG_215256 - Draft Guidance on Semaglutide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:58Z", null, 1, 0, "09000064b90aee64"], ["FDA-2007-D-0369-2406", "FDA", "FDA-2007-D-0369", "PSG_021938 - Draft Guidance on Sunitinib Malate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:03Z", null, 1, 0, "09000064b90aee66"], ["FDA-2007-D-0369-2408", "FDA", "FDA-2007-D-0369", "PSG_217439 - Draft Guidance on Talazoparib Tosylate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:13Z", null, 1, 0, "09000064b90aee6a"], ["FDA-2007-D-0369-2413", "FDA", "FDA-2007-D-0369", "PSG_215866 - Draft Guidance on Tirzepatide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:38Z", null, 1, 0, "09000064b90aee74"], ["FDA-2007-D-0369-2391", "FDA", "FDA-2007-D-0369", "PSG_217171 - Draft Guidance on Pegcetacoplan", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:12Z", null, 1, 0, "09000064b90aee48"], ["FDA-2007-D-0369-2400", "FDA", "FDA-2007-D-0369", "PSG_217604 - Draft Guidance on Pyridostigmine Bromide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:11:19Z", null, 1, 0, "09000064b90aee5a"], ["FDA-2007-D-0369-2389", "FDA", "FDA-2007-D-0369", "PSG_213593 - Draft Guidance on Omeprazole; Sodium Bicarbonate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:02Z", null, 1, 0, "09000064b90aee44"], ["FDA-2007-D-0369-2387", "FDA", "FDA-2007-D-0369", "PSG_206321 - Draft Guidance on Liraglutide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:09:51Z", null, 1, 0, "09000064b90aee40"], ["FDA-2007-D-0369-2350", "FDA", "FDA-2007-D-0369", "PSG_022556 - Draft Guidance on Carbinoxamine Maleate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:45:51Z", null, 1, 0, "09000064b90ae580"], ["FDA-2007-D-0369-2371", "FDA", "FDA-2007-D-0369", "PSG_212102 - Draft Guidance on Fenfluramine Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:54:52Z", null, 1, 0, "09000064b90aee1b"], ["FDA-2007-D-0369-2361", "FDA", "FDA-2007-D-0369", "PSG_218711 - Draft Guidance on Docetaxel", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:48:45Z", null, 1, 0, "09000064b90aee07"], ["FDA-2007-D-0369-2376", "FDA", "FDA-2007-D-0369", "PSG_210134 - Draft Guidance on Glucagon", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:03Z", null, 1, 0, "09000064b90aee25"], ["FDA-2007-D-0369-2357", "FDA", "FDA-2007-D-0369", "PSG_214231 - Draft Guidance on Dasiglucagon Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:47:34Z", null, 1, 0, "09000064b90ae58e"], ["FDA-2007-D-0369-2340", "FDA", "FDA-2007-D-0369", "PSG_214927 - Draft Guidance on Arimoclomol Citrate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:43:26Z", null, 1, 0, "09000064b90ae56e"], ["FDA-2007-D-0369-2345", "FDA", "FDA-2007-D-0369", "PSG_215935 - Draft Guidance on Budesonide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:44:28Z", null, 1, 0, "09000064b90ae578"], ["FDA-2007-D-0369-2418", "FDA", "FDA-2007-D-0369", "PSG_214938 - Draft Guidance on Vosoritide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-08T10:00:23Z", null, 1, 0, "09000064b90aee7e"], ["FDA-2007-D-0369-2359", "FDA", "FDA-2007-D-0369", "PSG_218730 - Draft Guidance on Deutivacaftor; Tezacaftor; Vanzacaftor Calcium", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:48:17Z", null, 1, 0, "09000064b90aee03"], ["FDA-2007-D-0369-2373", "FDA", "FDA-2007-D-0369", "PSG_020121 - Draft Guidance on Fluticasone Propionate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:55:30Z", null, 1, 0, "09000064b90aee1f"], ["FDA-2007-D-0369-2358", "FDA", "FDA-2007-D-0369", "PSG_017922 - Draft Guidance on Desmopressin Acetate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:47:49Z", null, 1, 0, "09000064b90ae590"], ["FDA-2007-D-0369-2384", "FDA", "FDA-2007-D-0369", "PSG_205388 - Draft Guidance on Ketorolac Tromethamine; Phenylephrine Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:57:07Z", null, 1, 0, "09000064b90aee3a"], ["FDA-2007-D-0369-2352", "FDA", "FDA-2007-D-0369", "PSG_216165 - Draft Guidance on Cefepime Hydrochloride; Enmetazobactam", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:46:18Z", null, 1, 0, "09000064b90ae584"], ["FDA-2007-D-0369-2380", "FDA", "FDA-2007-D-0369", "PSG_216016 - Draft Guidance on Iomeprol", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:36Z", null, 1, 0, "09000064b90aee2d"], ["FDA-2007-D-0369-2363", "FDA", "FDA-2007-D-0369", "PSG_217660 - Draft Guidance on Elexacaftor, Ivacaftor, Tezacaftor; Ivacaftor", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:49:16Z", null, 1, 0, "09000064b90aee0b"], ["FDA-2007-D-0369-2372", "FDA", "FDA-2007-D-0369", "PSG_215168 - Draft Guidance on Flurpiridaz F-18", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:55:21Z", null, 1, 0, "09000064b90aee1d"], ["FDA-2007-D-0369-2342", "FDA", "FDA-2007-D-0369", "PSG_207924 - Draft Guidance on Baricitinib", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:43:47Z", null, 1, 0, "09000064b90ae572"], ["FDA-2007-D-0369-2347", "FDA", "FDA-2007-D-0369", "PSG_215430 - Draft Guidance on Bupropion Hydrochloride; Dextromethorphan Hydrobromide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:44:56Z", null, 1, 0, "09000064b90ae57c"], ["FDA-2007-D-0369-2341", "FDA", "FDA-2007-D-0369", "PSG_017851 - Draft Guidance on Baclofen", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:43:37Z", null, 1, 0, "09000064b90ae570"], ["FDA-2007-D-0369-2410", "FDA", "FDA-2007-D-0369", "PSG_213931 - Draft Guidance on Tenapanor Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:23Z", null, 1, 0, "09000064b90aee6e"], ["FDA-2007-D-0369-2395", "FDA", "FDA-2007-D-0369", "PSG_214770 - Draft Guidance on Poscaconazole", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:33Z", null, 1, 0, "09000064b90aee50"], ["FDA-2007-D-0369-2403", "FDA", "FDA-2007-D-0369", "PSG_217242 - Draft Guidance on Roflumilast", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-23T10:00:12Z", null, 1, 0, "09000064b90aee60"], ["FDA-2007-D-0369-2415", "FDA", "FDA-2007-D-0369", "PSG_214324 - Draft Guidance on Treprostinil", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:48Z", null, 1, 0, "09000064b90aee78"], ["FDA-2007-D-0369-2386", "FDA", "FDA-2007-D-0369", "PSG_022341 - Draft Guidance on Liraglutide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:09:46Z", null, 1, 0, "09000064b90aee3e"], ["FDA-2007-D-0369-2396", "FDA", "FDA-2007-D-0369", "PSG_019561 - Draft Guidance on Potassium chloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:38Z", null, 1, 0, "09000064b90aee52"], ["FDA-2007-D-0369-2416", "FDA", "FDA-2007-D-0369", "PSG_017340 - Draft Guidance on Tretinoin", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:12:53Z", null, 1, 0, "09000064b90aee7a"], ["FDA-2007-D-0369-2394", "FDA", "FDA-2007-D-0369", "PSG_216483 - Draft Guidance on Pivmecillinam Hydrochloride", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T23:10:28Z", null, 1, 0, "09000064b90aee4e"], ["FDA-2007-D-0369-2349", "FDA", "FDA-2007-D-0369", "PSG_017769 - Draft Guidance on Calcitonin Salmon", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:45:35Z", null, 1, 0, "09000064b90af592"], ["FDA-2007-D-0369-2378", "FDA", "FDA-2007-D-0369", "PSG_018303 - Draft Guidance on Hydrochlorothiazide; Metoprolol Tartrate", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:56:19Z", null, 1, 0, "09000064b90aee29"], ["FDA-2007-D-0369-2354", "FDA", "FDA-2007-D-0369", "PSG_218808 - Draft Guidance on Crinecerfont", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:46:46Z", null, 1, 0, "09000064b90ae588"], ["FDA-2007-D-0369-2348", "FDA", "FDA-2007-D-0369", "PSG_020664 - Draft Guidance on Cabergoline", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:45:11Z", null, 1, 0, "09000064b90ae57e"], ["FDA-2007-D-0369-2355", "FDA", "FDA-2007-D-0369", "PSG_218820 - Draft Guidance on Crinecerfont", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:46:59Z", null, 1, 0, "09000064b90ae58a"], ["FDA-2007-D-0369-2346", "FDA", "FDA-2007-D-0369", "PSG_020929 - Draft Guidance on Budesonide", "Other", "Guidance", "2025-12-05T05:00:00Z", 2025, 12, "2025-12-05T05:00:00Z", "2026-02-04T04:59:59Z", "2025-12-05T20:44:46Z", null, 1, 0, "09000064b90ae57a"], ["FDA-2007-D-0369-2337", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2025-12-05T05:00:00Z", 2025, 12, null, null, "2025-12-05T19:22:56Z", "2025-22131", 0, 0, "09000064b90b00b7"], ["FDA-2007-D-0369-2297", "FDA", "FDA-2007-D-0369", "PSG_022383 - Draft Guidance on Indacaterol Maleate", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:09:40Z", null, 1, 0, "09000064b908bac8"], ["FDA-2007-D-0369-2272", "FDA", "FDA-2007-D-0369", "PSG_021658 - Draft Guidance on Ciclesonide", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:07:23Z", null, 1, 0, "09000064b908c9be"], ["FDA-2007-D-0369-2281", "FDA", "FDA-2007-D-0369", "PSG_207534 - Draft Guidance on Epinephrine", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:08:11Z", null, 1, 0, "09000064b908baa8"], ["FDA-2007-D-0369-2325", "FDA", "FDA-2007-D-0369", "PSG_218010 - Draft Guidance on Travoprost", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:12:07Z", null, 1, 0, "09000064b908ca20"], ["FDA-2007-D-0369-2264", "FDA", "FDA-2007-D-0369", "PSG_217424 - Draft Guidance on Berdazimer Sodium", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:06:35Z", null, 1, 0, "09000064b908c9ae"], ["FDA-2007-D-0369-2329", "FDA", "FDA-2007-D-0369", "PSG_209241 - Draft Guidance on Valbenazine Tosylate", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:12:31Z", null, 1, 0, "09000064b908ca28"], ["FDA-2007-D-0369-2285", "FDA", "FDA-2007-D-0369", "PSG_210589 - Draft Guidance on Fish Oil Triglycerides", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:08:35Z", null, 1, 0, "09000064b908bab0"], ["FDA-2007-D-0369-2301", "FDA", "FDA-2007-D-0369", "PSG_204410 - Draft Guidance on Draft Guidance on Macitentan", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:10:01Z", null, 1, 0, "09000064b908bad0"], ["FDA-2007-D-0369-2276", "FDA", "FDA-2007-D-0369", "PSG_216099 - Draft Guidance on Dasatinib", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:07:45Z", null, 1, 0, "09000064b908ba9e"], ["FDA-2007-D-0369-2290", "FDA", "FDA-2007-D-0369", "PSG_210828 - Draft Guidance on Gallium GA 68 Edotreotide", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:09:02Z", null, 1, 0, "09000064b908baba"], ["FDA-2007-D-0369-2310", "FDA", "FDA-2007-D-0369", "PSG_208051 - Draft Guidance on Neratinib Maleate", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:10:48Z", null, 1, 0, "09000064b908ca02"], ["FDA-2007-D-0369-2326", "FDA", "FDA-2007-D-0369", "PSG_216158 - Draft Guidance on Trospium Chloride; Xanomeline Tartrate", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:12:13Z", null, 1, 0, "09000064b908ca22"], ["FDA-2007-D-0369-2312", "FDA", "FDA-2007-D-0369", "PSG_204508 - Draft Guidance on Olive Oil; Soybean Oil", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:10:58Z", null, 1, 0, "09000064b908ca06"], ["FDA-2007-D-0369-2273", "FDA", "FDA-2007-D-0369", "PSG_213227 - Draft Guidance on Copper CU-64 Dotatate", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:07:28Z", null, 1, 0, "09000064b908c9c0"], ["FDA-2007-D-0369-2304", "FDA", "FDA-2007-D-0369", "PSG_216755 - Draft Guidance on Metronidazole", "Other", "Guidance", "2025-11-21T05:00:00Z", 2025, 11, "2025-11-21T05:00:00Z", "2026-01-21T04:59:59Z", "2025-11-21T20:10:18Z", null, 1, 0, "09000064b908c9d8"]], "truncated": false, "filtered_table_rows_count": 299, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2007-D-0369", "p1": "2025"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025", "results": [{"value": "FDA", "label": "FDA", "count": 299, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025", "results": [{"value": "Other", "label": "Other", "count": 291, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025", "results": [{"value": 2025, "label": 2025, "count": 299, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_facet_date=last_modified"}], "next": "2025-11-21T05~3A00~3A00Z,FDA-2007-D-0369-2304", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2025&_next=2025-11-21T05~3A00~3A00Z%2CFDA-2007-D-0369-2304&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1464.0411229920574, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}